| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.46 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.097 | 0.03 |